Dongbao Enterprise Group Co., Ltd. Company Profile,Dongbao Enterprise Group Co., Ltd. Essential Information

We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

Dongbao Enterprise Group Co., Ltd.

Fifteen years of qualification

Audited Supplier

In This Store

In This Store
On Pharma Sources.com

Favorites

Company Profile

Our Company Our Business

Year Established : 1992

Send Inquiry

Dongbao Enterprise Group Co. Ltd. is a leading biopharmaceutical company actively engaged in R&D, production and marketing of high-quality biological products. As one of the well-known manufacturer of RH insulin, in the segment of diabetes mellitus, we have also developed glargine, aspart, lispro and degludec, as well as liraglutide and delaglutide. In Dongbao’s biotech portfolio, different monoclonal antibodies (adalimumab, etanercept and rituximab), recombinant human albumin and recombinant coagulation factor VII & VIII are also well developed.

Company Profile of Dongbao Enterprise Group Co., Ltd.

Company Profile